TECON BIOLOGYLTD Balance Sheet Health
Financial Health criteria checks 4/6
TECON BIOLOGYLTD has a total shareholder equity of CN¥8.5B and total debt of CN¥5.3B, which brings its debt-to-equity ratio to 62.1%. Its total assets and total liabilities are CN¥16.9B and CN¥8.4B respectively.
Key information
62.1%
Debt to equity ratio
CN¥5.27b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥3.66b |
| Equity | CN¥8.48b |
| Total liabilities | CN¥8.44b |
| Total assets | CN¥16.92b |
Recent financial health updates
TECON BIOLOGYLTD (SZSE:002100) Is Carrying A Fair Bit Of Debt
Sep 26
TECON BIOLOGYLTD (SZSE:002100) Is Making Moderate Use Of Debt
May 11Recent updates
TECON BIOLOGY Co.LTD (SZSE:002100) Could Be Riskier Than It Looks
Oct 28TECON BIOLOGYLTD (SZSE:002100) Is Carrying A Fair Bit Of Debt
Sep 26Sentiment Still Eluding TECON BIOLOGY Co.LTD (SZSE:002100)
Jul 12TECON BIOLOGYLTD (SZSE:002100) Is Making Moderate Use Of Debt
May 11Why Investors Shouldn't Be Surprised By TECON BIOLOGY Co.LTD's (SZSE:002100) Low P/S
Apr 12Financial Position Analysis
Short Term Liabilities: 002100's short term assets (CN¥9.1B) exceed its short term liabilities (CN¥6.2B).
Long Term Liabilities: 002100's short term assets (CN¥9.1B) exceed its long term liabilities (CN¥2.3B).
Debt to Equity History and Analysis
Debt Level: 002100's net debt to equity ratio (18.9%) is considered satisfactory.
Reducing Debt: 002100's debt to equity ratio has reduced from 77.5% to 62.1% over the past 5 years.
Debt Coverage: 002100's debt is not well covered by operating cash flow (11.4%).
Interest Coverage: Insufficient data to determine if 002100's interest payments on its debt are well covered by EBIT.